Life Science Investing: World

Gloved hand holds a cluster of brown mushrooms growing from a gray substrate block.

Psychedelics Market Trends: H1 2026 Review and Forecast

As federal policies shift, the psychedelic medicine market is transitioning from speculative research to a prescription-oriented framework. Could 2026 be a breakthrough year for psychedelic therapies?

Psychedelics Investing
Latest Articles
Company Profiles
CCO:AU

The Calmer Co

CCO:AU

Providing kava-based natural solutions for wellness and relaxation

Psychedelics Investing
MRVL:CC

Marvel Biosciences

MRVL:CC

Developing a human-trial-ready pan-spectrum treatment for autism and other neurological disorders

Pharmaceutical Investing
BCT:CC

BriaCell Therapeutics

BCT:CC

Redefining Oncology with Personalized Cancer Immunotherapy

Biotech Investing
life science News
Editors' Picks
MARKETS
COMMODITIES
CURRENCIES